MEDTR.E — Meditera Tibbi Malzeme Sanayi ve Ticaret AS Cashflow Statement
0.000.00%
Last trade - 00:00- TRY4.49bn
- TRY4.20bn
- TRY1.45bn
- 56
- 27
- 42
- 33
Annual cashflow statement for Meditera Tibbi Malzeme Sanayi ve Ticaret AS, fiscal year end - December 31st, millions except per share.
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | |
| Standards: | — | IFRS | IFRS | IFRS | IFRS |
| Status: | fx Preliminary | Final | Final | Final | Final |
| Net Income/Starting Line | — | 60.4 | 168 | 114 | 25.9 |
| Depreciation | |||||
| Non-Cash Items | — | 4.49 | -113 | 65.5 | 339 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | — | -3.68 | -29.8 | -565 | -277 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | — | 73.3 | 36.6 | -335 | 140 |
| Capital Expenditures | — | -21.4 | -9.23 | -92 | -208 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | -1.12 | 2.9 | 11.4 | 206 |
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | — | -22.5 | -6.33 | -80.6 | -1.69 |
| Financing Cash Flow Items | — | -3.15 | 3.72 | -11.8 | 2.76 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | — | -1.03 | 175 | -130 | -149 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | — | 49.7 | 205 | -546 | -11.1 |